Navigation Links
Last chance for media to pre-register for Europe's largest cancer congress: ECCO15-ESMO34
Date:9/11/2009

ur burden and survival in melanoma patients, sparing unnecessary surgery.
  • Innovative test for new cancer drugs will lead to quicker validation and safer and more efficient clinical trials.
  • Keep taking the medicine: study of adjuvant endocrine treatment for breast cancer reveals the cost of patient non-compliance.
  • Switching early breast cancer patients to exemestane improves long-term survival.
  • Findings of the first study of teen experiences during the process of obtaining a cancer diagnosis.


    '/>"/>


  • Contact: Emma Mason
    wordmason@mac.com
    44-771-129-6986
    ECCO-the European CanCer Organisation
    Source:Eurekalert

    Page: 1 2 3

    Related biology news :

    1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
    2. Age increases chance of success as two-timer
    3. UV light improving chances of fighting cancer
    4. Research forecasts increased chances for stormy weather
    5. TB bacterium uses its sugar coat to sweeten its chances of living in lungs
    6. New CU-Boulder study shows diversity decreases chances of parasitic disease
    7. Blood test predicts chance of dementia
    8. Work of Field Museum scientist addresses question of chance in evolution
    9. They are young and need the job: A second chance for dangerous T-cells
    10. September Geology and GSA Today media highlights
    11. Heart of Herschel to be presented to media
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/10/2014)... SUNNYVALE, California , December 9, 2014 /PRNewswire/ ... Integrate with ITN,s BCARD Platform ... secure, cloud-based enterprise meeting scheduling solutions for business-to-business ... International, the world leader in mobile near-field communication ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
    (Date:12/4/2014)... GARDENS, Fla. , Dec. 3, 2014 /PRNewswire/ ... solutions, today announced that its DigitalPersona ® ... fingerprint readers have been deployed throughout First Bank ... , South Carolina and ... in Southern Pines, North Carolina ...
    (Date:11/21/2014)... , November 18, 2014 ... Systems Market by Systems (Video, RFID, Access Control, Intrusion ... Factories, Hotels, Banks, Government), Component Service Geography - Global ... Systems Market is projected to be around $25 Billion ... by 2020, growing at a CAGR of 8.69%. ...
    Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
    ... the world's oceans are severely threatened by over-fishing and ... fishes' long lifespans and low reproductive success, a panel ... the American Association of the Advancement of Science. Some ... 500 meters take decades to reach breeding maturity, so ...
    ... to knock out a specific protein that protects cancer cells ... suggest that a drug that can block this "survival protein" ... , But such a drug used in combination with several ... drug-resistant forms of chronic lymphocytic leukemia (CLL) and acute lymphoblastic ...
    ... patients in Uganda who self-paid for their antiretroviral medications ... demands or supply logistical disruptions. These treatment interruptions ... in patients. , These findings by a team led ... University, Kampala, and UCSF are reported in the April ...
    Cached Biology News:Long-lived deep-sea fishes imperiled by technology, overfishing 2Long-lived deep-sea fishes imperiled by technology, overfishing 3Knocking out survival protein could aid leukemia treatment 2Resistance to anti-HIV drugs in Uganda developed due to drug supply problems 2
    (Date:12/19/2014)... LayerBio is an MIT spin-off developing novel ... National Eye Institute (NEI) at the National Institutes of ... grant to develop a drug-eluting intraocular lens (IOL) for ... of vision loss in people over age 40 and ... Ken Mandell, LayerBio’s Founder and CEO, "There is a ...
    (Date:12/19/2014)... 2014 The empty capsules market ... ageing population and technological innovations in the empty ... are catalysing the growth of the empty capsules ... , Scope of Report , The report ... new entrants/smaller firms to gauge the pulse of ...
    (Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
    (Date:12/17/2014)... RIDGE, N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today ... mg (referred to as Somatuline®) was approved by ... the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in ... locally advanced or metastatic disease to improve progression-free ...
    Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
    ... from Thomson Reuters released today shows that the US is no ... kept pace with the increased output from European and Asia-Pacific nations. ... found that research output from the US has been surpassed by ... 40 percent of research papers in the most influential journals(1). By ...
    ... [Brown University] The website of the Nobel Prize ... fictitious, the image captures the excitement around graphene, which, ... and strongest materials ever produced. A significant obstacle ... large enough to support a theoretical sleeping cat. For ...
    ... This release is available in German ... and smaller, with microelectronic components gradually being replaced ... is at the present stage the most commonly ... limit, preventing further miniaturization and technological progress. New ...
    Cached Biology Technology:US Dominance in Scientific Research Significantly Challenged by Increased Competition from Europe and Asia, According to Thomson Reuters Study 2Graphene's strength lies in its defects 2Step by step toward tomorrow's nanomaterial 2
    Human PLUNC MAb (Clone 252512)...
    BOND ELUT MATRIX-C18, 25 mg ...
    Human FADD Affinity Purified Polyclonal Ab...
    Immunogen: Synthetic peptide based on the sequence: SPSSGPSLTADSMWR Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Biology Products: